Diagnostic Cholangiopancreatography

As in recent years, the articles on diagnostic endoscopic retrograde cholangiopancreatography (ERCP) published between July 2001 and June 2002 again reflect a defensive attitude and are mainly concerned with magnetic resonance cholangiopancreatography (MRCP) and the complications associated with the new imaging method. Diagnostic ERCP is declining in importance and has held its position mainly due to new advances in tissue sampling, pressure measurement, and the use of echo probes and miniature endoscopes. Problems of training in ERCP have still not yet been resolved, due to the contradictions inherent in low case loads, the desire to offer a wide spectrum of training, and issues of quality assurance.

References

• 1 Menon K, Barkun A N, Romagnuolo J. et al . Patient satisfaction after MRCP and ERCP.  Am J Gastroenterol. 2001;  96 2646-2650
• 2 Farrell R J, Noonan N, Mahmud N. et al . Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain.  Endoscopy. 2001;  33 668-675
• 3 Sahai A V, Devonshire D, Yeoh K G. et al . The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease.  Am J Gastroenterol. 2001;  96 2074-2080
• 4 Rösch T, Meining A, Frühmorgen S. et al . A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures.  Gastrointest Endosc. 2002;  55 870-876
• 5 Urban M, Holzer B, Sebesta C. et al . Efficacy of diagnosis of mechanical cholestasis by magnetic resonance cholangiography.  World J Surg. 2002;  26 353-358
• 6 Taylor A C, Little A F, Hennessy O F. et al . Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree.  Gastrointest Endosc. 2002;  55 17-22
• 7 Laokpessi A, Bouillet P, Sautereau D. et al . Value of magnetic resonance cholangiography in the preoperative diagnosis of common bile duct stones.  Am J Gastroenterol. 2001;  96 2354-2359
• 8 Lopera J E, Soto J A, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.  Radiology. 2001;  220 90-96
• 9 Harewood G C, Baron T H. Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction.  Am J Gastroenterol. 2002;  97 1152-1158
• 10 Chaudhary A, Negi S S, Puri S K, Narang P. Comparison of magnetic resonance cholangiography and percutaneous transhepatic cholangiography in the evaluation of bile duct strictures after cholecystectomy.  Br J Surg. 2002;  89 433-436
• 11 Calvo M M, Bujanda L, Calderon A. et al . Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct.  Am J Gastroenterol. 2002;  97 347-353
• 12 Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M. Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation.  Radiology. 2002;  222 674-680
• 13 Varghese J C, Masterson A, Lee M J. Value of MR pancreatography in the evaluation of patients with chronic pancreatitis.  Clin Radiol. 2002;  57 393-401
• 14 Izuishi K, Nakagohri T, Konishi M. et al . Spatial assessment by magnetic resonance cholangiopancreatography for preoperative imaging in partial pancreatic head resection.  Am J Surg. 2001;  182 188-191
• 15 Kodama T, Koshitani T, Sato H. et al . Electronic pancreatoscopy for the diagnosis of pancreatic diseases.  Am J Gastroenterol. 2002;  97 617-622
• 16 Koito K, Namieno T, Hirokawa N. et al . Virtual CT cholangioscopy: comparison with fiberoptic cholangioscopy.  Endoscopy. 2001;  33 676-681
• 17 Seitz U, Freund J, Jaeckle S. et al . First in vivo optical coherence tomography in the human bile duct.  Endoscopy. 2001;  33 1018-1021
• 18 Poneros J M, Tearney G J, Shiskov M. et al . Optical coherence tomography of the biliary tree during ERCP.  Gastrointest Endosc. 2002;  55 84-88
• 19 van Heek N T, Rauws E A, Caspers E. et al . Long-term follow-up of patients with a clinically benign extrahepatic biliary stenosis and K-ras mutation in endobiliary brush cytology.  Gastrointest Endosc. 2002;  55 883-888
• 20 Boadas J, Mora J, Urgell E. et al . Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.  Eur J Gastroenterol Hepatol. 2001;  13 1153-1159
• 21 O’Mahony S, Sreedharan A. Does detection of K-ras mutations in pancreatic juice influence clinical decision-making ?.  Eur J Gastroenterol Hepatol. 2001;  13 1141-1142
• 22 Pugliese V, Pujic N, Saccomanno S. et al . Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.  Gastrointest Endosc. 2001;  54 595-599
• 23 Farrell R J, Jain A K, Brandwein S L. et al . The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures.  Gastrointest Endosc. 2001;  54 587-594
• 24 Fazel A, Burton F R. The effect of midazolam on the normal sphincter of Oddi: a controlled study.  Endoscopy. 2002;  34 78-81
• 25 Fazel A, Burton F R. A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility.  Gastrointest Endosc. 2002;  55 637-640
• 26 Quallich L G, Stern M A, Rich M. et al . Bile duct crystals do not contribute to sphincter of Oddi dysfunction.  Gastrointest Endosc. 2002;  55 163-166
• 27 Sharma S S. Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity.  Gastrointest Endosc. 2002;  55 427-430
• 28 Rosenblatt M L, Catalano M F, Alcocer E, Geenen J E. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction.  Gastrointest Endosc. 2001;  54 697-704
• 29 Cohen M E, Slezak L, Wells C K. et al . Prediction of bile duct stones and complications in gallstone pancreatitis using early laboratory trends.  Am J Gastroenterol. 2001;  96 3305-3311
• 30 Kohut M, Nowak A, Nowakowska-Dulawa E. et al . The frequency of bile duct crystals in patients with presumed biliary pancreatitis.  Gastrointest Endosc. 2001;  54 37-41
• 31 Kaw M, Brodmerkel G J. ERCP, biliary crystal analysis and sphincter of Oddi manometry in idiopathic recurrent pancreatitis.  Gastrointest Endosc. 2002;  55 157-162
• 32 Levy M J. The hunt for microlithiasis in idiopathic acute recurrent pancreatitis: should we abandon the search or intensify our efforts?.  Gastrointest Endosc. 2002;  55 286-293
• 33 Kim J E, Lee J K, Lee K T. et al . The clinical significance of common bile duct dilatation in patients without biliary symptoms or causative lesions on ultrasonography.  Endoscopy. 2001;  33 495-500
• 34 Kama N A, Atli M, Doganay M. et al . Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones.  Surg Endosc. 2001;  15 942-945
• 35 Christoforidis E, Goulimaris I, Kanellos I. et al . The role of juxtapapillary duodenal diverticula in biliary stone disease.  Gastrointest Endosc. 2002;  55 543-547
• 36 Zoepf T, Zoepf D S, Arnold J C. et al . The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients.  Gastrointest Endosc. 2001;  54 56-61
• 37 Nomura T, Shirai Y, Sandoh N. et al . Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts.  Gastrointest Endosc. 2002;  55 204-208
• 38 Kim H J, Kim M H, Lee S K. et al . Normal structure, variations, and anomalies of the pancreaticobiliary ducts of Koreans: a nationwide cooperative prospective study.  Gastrointest Endosc. 2002;  55 889-896
• 39 Wilcox C M. Endoscopic examination with the duodenoscope at ERCP: frequency of lesions and accuracy of detection.  Gastrointest Endosc. 2002;  55 538-542
• 40 Horiuchi A, Kawa S, Hamano H. et al . ERCP features in 27 patients with autoimmune pancreatitis.  Gastrointest Endosc. 2002;  55 494-499
• 41 Park J S, Kim M H, Lee S K. et al . The clinical significance of papillitis of the major duodenal papilla.  Gastrointest Endosc. 2002;  55 877-882
• 42 Ahuja V, Garg P K, Kumar D. et al . Presence of white bile associated with lower survival in malignant biliary obstruction.  Gastrointest Endosc. 2002;  55 186-191
• 43 Johlin F C, Pelsang R E, Greenleaf M. Phantom study to determine radiation exposure to medical personnel involved in ERCP fluoroscopy and its reduction through equipment and behavior modifications.  Am J Gastroenterol. 2002;  97 893-897
• 44 Campbell N, Sparrow K, Fortier M, Ponich T. Practical radiation safety and protection for the endoscopist during ERCP.  Gastrointest Endosc. 2002;  55 552-557
• 45 Rabenstein T, Roggenbuck S, Framke B. et al . Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?.  Gastrointest Endosc. 2002;  55 476-483
• 46 Rabenstein T, Hahn E G. Post-ERCP pancreatitis: new momentum.  Endoscopy. 2002;  34 325-329
• 47 Dumot J A, Conwell D L, Zuccaro G. et al . A randomized, double-blind study of interleukin-10 for the prevention of ERCP-induced pancreatitis.  Am J Gastroenterol. 2001;  96 2098-2102
• 48 Devière J, Le Moine O, van Laethem J L. et al . Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.  Gastroenterology. 2001;  120 498-505
• 49 Budzynska A, Marek T, Nowak A. et al . A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.  Endoscopy. 2001;  33 766-772
• 50 Manolakopoulos S, Avgerinos A, Vlachogiannakos J. et al . Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.  Gastrointest Endosc. 2002;  55 470-475
• 51 Sudhindran S, Bromwich E, Edwards P R. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.  Br J Surg. 2001;  88 1178-1182
• 52 Friedland S, Soetikno R M, Vandervoort J. et al . Bedside scoring system to predict the risk of developing pancreatitis following ERCP.  Endoscopy. 2002;  34 483-488
• 53 Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis.  Gastrointest Endosc. 2001;  54 435-440
• 54 Akashi R, Kiyozumi T, Tanaka T. et al . Mechanism of pancreatitis caused by ERCP.  Gastrointest Endosc. 2002;  55 50-54
• 55 Christoforidis E, Goulimaris I, Kanellos I. et al . Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.  Endoscopy. 2002;  34 286-292
• 56 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434